Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,058
datasets available to search
ShareScore release 0.9.0
Dataset results
1,058 results for “ARDS”
Sesleria caerulea (L.) Ard. (BR0000011610007)
Belgium Herbarium image of <a href="https://www.plantentuinmeise.be">Meise Botanic Garden</a>.
Sesleria caerulea (L.) Ard. (BR0000011609452)
Belgium Herbarium image of <a href="https://www.plantentuinmeise.be">Meise Botanic Garden</a>.
Sesleria caerulea (L.) Ard. (BR0000011608103)
Belgium Herbarium image of <a href="https://www.plantentuinmeise.be">Meise Botanic Garden</a>.
Sesleria caerulea (L.) Ard. (BR0000012408276)
Belgium Herbarium image of <a href="https://www.plantentuinmeise.be">Meise Botanic Garden</a>.
Sesleria caerulea (L.) Ard. (BR0000012407774)
Belgium Herbarium image of <a href="https://www.plantentuinmeise.be">Meise Botanic Garden</a>.
Sesleria caerulea (L.) Ard. (BR0000010970775)
Belgium Herbarium image of <a href="https://www.plantentuinmeise.be">Meise Botanic Garden</a>.
Sesleria caerulea (L.) Ard. (BR0000010668887)
Belgium Herbarium image of <a href="https://www.plantentuinmeise.be">Meise Botanic Garden</a>.
Effectiveness of prone positioning in non-intubated ICU patients with moderate to severe ARDS
<p><strong>Data and R code from the paper</strong></p> <p><em><strong>Effectiveness of prone positioning in non-intubated ICU patients with moderate to severe ARDS</strong></em></p> <p>Authors:</p> <p>Manuel Taboada, Ph.D. Mariana González, M.D. Antía Álvarez, M.D., Irene González, M.D, Javier García, M.D., María Eiras. M.D., María Diaz Vieito, M.D., Alberto Naveira, M.D., Pablo Otero, M.D., Olga Campaña, M.D., Ignacio Muniategui, M.D., Ana Tubio, M.D., Jose Costa, M.D., Salomé Selas, M.D., Agustín Cariñena, M.D., Adrián Martínez, M.D., Sonia Veiras, M.D. Ph.D, Francisco Aneiros, M.D., Valentín Caruezo, M.D., Aurora Baluja, M.D. Julian Alvarez, Ph.D<br> <br> <strong>Background</strong>:<br> In the treatment for severe ARDS from COVID-19, the WHO recommends prone positioning (PP) during mechanical ventilation for periods of 12-16 hours per day to potentially improve oxygenation and survival. In this prospective observational study we evaluated the ability of long PP sessions to improve oxygenation in awake ICU patients with moderate or severe ARDS due to COVID-19.</p> <p><strong>Methods</strong>:<br> The study was approved by the ethics committee of Galicia (code No. 2020-188), and all patients provided informed consent. In this case series, awake patients with moderate or severe ARDS by COVID-19 admitted to the ICU at University Hospital of Santiago from March 21 to April 5, 2020 were prospectively analyzed. Patients were instructed to remain in PP as long as possible and not stop until the they felt too tired to maintain that position. If needed, light sedation was administered. The following information were collected: StO2 and blood gases (PaO2, PaO2/FiO2, PaCO2, pH) in ICU admission, number and duration of PP sessions, StO2 and blood gases before, during and following a PP session, need of mechanical ventilation, duration of ICU admission and ICU outcome. Linear mixed effects models (LMM) were adjusted to estimate changes of oxygenation parameters from baseline,. Patients were added as a random effect to account for inter-patient random variability in their own baseline measurements.</p> <p><strong>Results</strong>:<br> Seven patients with moderate or severe ARDS by COVID-19 were included. All patients received at least one PP session. A total of 16 PP sessions were performed in the 7 patients during the period study. The median duration of PP sessions was 10 hours. For PP sessions of more than 4 hours, dexmedetomidine was used for sedation. Oxygenation increased in all sixteen sessions performed in the seven patients. Prone positioning was associated to a net increase from baseline in PaO2, PaO2/FiO2 and StO2 (65, mmHg 110 and 2.6% respectively) PaO2/FiO2 increased during PP (Δ PaO2/FiO2 110.42 mmHg [28.173; 192.67]) and after PP (37.75 [-1.57; 77.07] compared with previous supine position (baseline PaO2FiO2 median-IQR97.8 [97.2 – 99.4]). Two patients required intubation. Six patients were discharged from the ICU and one remains on mechanical ventilation.</p> <p><strong>Conclusions</strong>:<br> We found that PP improved oxygenation and may avoid intubation in ICU patients with COVID-19 and moderate or severe ARDS. PP was relatively well tolerated in our patients. and may be a simple strategy to improve oxygenation trying to reduce patients in mechanical ventilation and the length of stay in the ICU, especially in the COVID-19 pandemic.</p> <p><strong>GitHub repository</strong>:</p> <p>https://github.com/medicalc/prone_sars</p>
Clach Ard Pictish Stone -Tote - Isle of Skye
Clach Ard Pictish Stone, Tote, Isle of Skye Clach Ard 'Tall Stone'. Approx 1.4m hight and 0.5m wide. Double disc and Z-rod, crescent and V-rod symbols. Grid Ref: NG 410 743 Source: Objaverse 1.0 / Sketchfab
Effects of the OLC following ARDSnet ventilation in patients with early ARDS
<p>Background: Ventilation with low tidal volume (VT) is well recognized as a protective approach to patients with acute respiratory distress syndrome (ARDS), but the optimal level of positive end-expiratory pressure (PEEP) remains uncertain. This study aims to evaluate two protective ventilatory strategies sequentially applied in patients with early ARDS. Methods: In this prospective cohort study, fifteen patients were ventilated during 24h with positive end-expiratory pressure (PEEP) adjusted according to the ARDSnet low-PEEP table (ARDSnet-24h). During the next 24h, nine patients with PaO2/FIO2 ratio below 350 mmHg were ventilated with PEEP titrated according to the Open Lung Concept protocol (ARDSnet+OLC). In the other six patients, regardless of their PaO2/FIO2 ratio, the ARDSnet remained for a further 24 h (ARDSnet-48h). Ventilatory variables, arterial bloodgas and cytokine were obtained at baseline, 24 and 48h. Additionally, whole-lungcomputed tomography was acquired at 24 and 48h. Results: A sustained improvement in PaO2/FIO2 ratio (P=0.008) with a decrease in collapsed regions (P=0.008) was observed in the ARDSnet+OLC group compared with the ARDSnet-24h group. A reduction in IL-6 in plasma (P<0.02) was observed throughout the protocol in the ARDSnet+OLC group. Compared with the ARDSnet-48h group, the ARDSnet+OLC presented smaller amounts of collapsed areas (P=0.018) without significant differences in hyperinflated regions and in driving and plateau pressures. Conclusions: In this set of patients with early ARDS, mechanical ventilation with an individually tailored PEEP sustained improved pulmonary function with better aeration, without significant increase in hyperinflated areas”</p>
USGS National Elevation Dataset (NED) DEM reprojected into Collection 2 Landsat analysis ready data (ARD) tiles
<p>This dataset is used to test the Classifying the raw irregular time series (CRIT) codes and model for CONUS land cover classification with a deep learning model that can directly classify Landsat irrigular time series. See the code here https://github.com/hankui/CRIT</p>
Proteomic profiling of survivors of SARS-CoV-2-induced ARDS
<p>Around 80% of patients who develop acute respiratory distress syndrome (ARDS) secondary to SARS-CoV-2 infection experience persistent lung dysfunction. The molecular factors that mediate pulmonary sequelae and recovery are unknown.<strong> </strong>In this context, we sought to comprehensively characterize the proteomic determinants of pulmonary diffusion impairment.<strong> </strong></p> <p>This was a prospective cohort study including eighty-seven SARS-CoV-2–induced ARDS survivors. A complete pulmonary function evaluation and chest computed tomography (CT) were performed 3 months after hospital discharge. Proteomic profiling (364 proteins) was performed in plasma samples using proximity extension assay (PEA) technology. Partial least squares-discriminant analysis (PLS-DA) and random forest (RF) methods were used to assess predictor importance.</p> <p>Thirty percent of patients presented moderate to severe impairment of lung diffusing capacity (D<sub>LCO</sub><60% predicted). In the univariate analysis, fifteen proteins showed high concentrations in patients with D<sub>LCO</sub><60% [false discovery rate (FDR)<0.05]. Pleiotrophin (PTN) displayed the highest differences: fold change=2.22 and FDR=0.001. Differentially detected proteins showed an inverse and independent dose–response relationship with D<sub>LCO</sub>. The multivariable approaches clustered proteins according to the severity of diffusion impairment. Clusters were composed of host mediators of cell proliferation and differentiation, tissue remodeling, angiogenesis, coagulation, inflammation, immune response and fibrosis signaling.</p> <p>In survivors of SARS-CoV-2–induced ARDS, lung diffusion impairment is associated with specific circulating factors implicated in multiple injury and repair mechanisms. The host protein signatures allow a better understanding of pulmonary sequelae and may constitute therapeutic targets and biomarkers. The long-term biological and clinical significance of these observations requires further investigation.</p>
Safety Study of Inhaled Carbon Monoxide to Treat Pneumonia and Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)
ClinicalTrials.gov study NCT04870125. IPD Sharing: YES. Countries: 1. Publications: 12.
Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
ClinicalTrials.gov study NCT04402970. IPD Sharing: NO. Countries: 1. Publications: 6.
Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II
ClinicalTrials.gov study NCT00789685. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate ARD-101 in Adults With Obesity
ClinicalTrials.gov study NCT05121441. IPD Sharing: NO. Countries: 1. Publications: 0.
Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
ClinicalTrials.gov study NCT04493242. IPD Sharing: NO. Countries: 1. Publications: 1.
Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset
ClinicalTrials.gov study NCT04729075. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS
ClinicalTrials.gov study NCT04429555. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19
ClinicalTrials.gov study NCT04615429. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.